This story has been corrected from a previous version, which incorrectly stated that Ronald Kahn was a co-founder of RealTime Health. He is on the company's scientific advisory board. 

BETHESDA, Md., Dec 4 – InforMax CEO Alex Titomirov said Tuesday he was launching a new start-up that would make gene expression-based preventive medicine technology available to individuals.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.